Shaf Keshavjee Selected Research

prostaglandin D3

1/2021	Cell-free DNA in human ex vivo lung perfusate as a potential biomarker to predict the risk of primary graft dysfunction in lung transplantation.
6/2015	The role of the endothelin-1 pathway as a biomarker for donor lung assessment in clinical ex vivo lung perfusion.
3/2015	Protein expression profiling predicts graft performance in clinical ex vivo lung perfusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shaf Keshavjee Research Topics

Disease

35	Neoplasms (Cancer) 10/2022 - 06/2002
30	Lung Injury 11/2022 - 12/2002
28	Primary Graft Dysfunction 12/2022 - 01/2004
23	Lung Diseases (Lung Disease) 04/2022 - 01/2003
20	Inflammation (Inflammations) 01/2022 - 01/2002
18	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 08/2002
17	Death (Near-Death Experience) 12/2022 - 08/2009
16	Reperfusion Injury 04/2022 - 01/2002
16	Infections 01/2022 - 12/2004
15	Acute Lung Injury 05/2021 - 01/2006
15	Ischemia 10/2018 - 01/2002
14	Lung Neoplasms (Lung Cancer) 10/2022 - 01/2007
13	Malignant Mesothelioma 01/2021 - 01/2007
12	Brain Death (Brain Dead) 01/2021 - 08/2006
12	Bronchiolitis Obliterans Syndrome 01/2016 - 05/2004
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 11/2004
8	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 02/2022 - 04/2003
7	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 07/2004
7	Sepsis (Septicemia) 01/2020 - 05/2004
7	Pulmonary Arterial Hypertension 12/2015 - 12/2005
6	Fibrosis (Cirrhosis) 01/2022 - 09/2005
6	Bronchiolitis 06/2012 - 11/2005
5	Mesothelioma 01/2021 - 07/2010
5	Necrosis 01/2021 - 10/2003
5	Edema (Dropsy) 01/2021 - 02/2003
5	Wounds and Injuries (Trauma) 01/2021 - 08/2006
5	Hypoxia (Hypoxemia) 12/2017 - 02/2003
5	Carcinoma (Carcinomatosis) 12/2012 - 01/2009
4	Pulmonary Hypertension 01/2022 - 12/2013
4	Myasthenia Gravis 01/2021 - 11/2003
4	Heart Arrest (Cardiac Arrest) 01/2021 - 10/2015
4	COVID-19 01/2021 - 01/2020
4	Invasive Pulmonary Aspergillosis 12/2020 - 11/2015
4	Pathologic Constriction (Stenosis) 01/2020 - 03/2009
4	Hemorrhage 12/2018 - 01/2007
4	Pulmonary Edema 01/2018 - 04/2011
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 12/2013
3	Aspergillosis 11/2020 - 09/2017
3	Gastroesophageal Reflux (GERD) 01/2020 - 10/2005
3	Emphysema 12/2019 - 10/2005
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2016 - 12/2012
3	Familial Primary Pulmonary Hypertension 06/2013 - 09/2011
3	Thyroid Neoplasms (Thyroid Cancer) 01/2013 - 01/2011
3	Esophageal Neoplasms (Esophageal Cancer) 10/2012 - 01/2009
3	Bronchiolitis Obliterans 10/2005 - 02/2002
2	Hepatitis C 12/2022 - 01/2020
2	Thymoma (Thymic Carcinoma) 01/2021 - 04/2014
2	Ventilator-Induced Lung Injury 12/2020 - 06/2005
2	Diabetes Mellitus 01/2020 - 12/2005
2	Cytomegalovirus Infections (Inclusion Disease) 12/2019 - 06/2015

Drug/Important Bio-Agent (IBA)

17	Prostaglandins DIBA 01/2021 - 05/2007
11	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2003
11	dicarboxydine (DCD)IBA 01/2021 - 08/2009
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2010
8	CytokinesIBA 01/2021 - 01/2002
5	Oxygen (Dioxygen)IBA 03/2022 - 01/2006
5	Interleukin-10 (Interleukin 10)IBA 12/2021 - 05/2003
5	LipopolysaccharidesIBA 05/2016 - 01/2007
4	Interleukin-6 (Interleukin 6)IBA 01/2021 - 05/2016
4	PTX3 proteinIBA 09/2017 - 12/2005
4	Small Interfering RNA (siRNA)IBA 01/2013 - 01/2011
4	FibrinIBA 05/2012 - 11/2009
3	prostaglandin D3IBA 01/2021 - 03/2015
3	MicroRNAs (MicroRNA)IBA 11/2020 - 10/2012
3	EnzymesIBA 01/2020 - 01/2003
3	serum P-component (CIt)IBA 01/2020 - 01/2016
3	RNA (Ribonucleic Acid)IBA 01/2020 - 03/2012
3	Pharmaceutical PreparationsIBA 01/2020 - 10/2005
3	Bile Acids and Salts (Bile Acids)IBA 01/2020 - 05/2005
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 11/2019 - 01/2015
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019 - 01/2014
3	Anesthetics (Anesthetic Agents)IBA 05/2017 - 12/2013
3	Peptides (Polypeptides)IBA 10/2016 - 06/2011
3	SolutionsIBA 05/2009 - 02/2003
3	salicylhydroxamic acid (SHAM)IBA 03/2008 - 01/2006
3	Complementary DNA (cDNA)IBA 11/2004 - 06/2002
2	AntigensIBA 01/2022 - 09/2010
2	Interleukin-17 (Interleukin 17)IBA 12/2021 - 04/2016
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2021 - 08/2007
2	Interleukin-8 (Interleukin 8)IBA 01/2021 - 07/2004
2	Dextrans (Dextran)FDA Link 01/2021 - 12/2004
2	Antiviral Agents (Antivirals)IBA 01/2020 - 01/2020
2	ImmunosorbentsIBA 01/2020 - 06/2017

Therapy/Procedure

99	Lung Transplantation 04/2022 - 12/2002
43	Transplantation 11/2022 - 01/2003
36	Therapeutics 10/2022 - 09/2004
17	Pneumonectomy (Lung Volume Reduction) 01/2021 - 02/2005
12	Extracorporeal Membrane Oxygenation 01/2022 - 08/2005
9	Radiotherapy 01/2021 - 07/2005
7	Artificial Respiration (Mechanical Ventilation) 09/2021 - 12/2002
6	Drug Therapy (Chemotherapy) 01/2020 - 07/2005
5	Thymectomy 01/2021 - 11/2003
5	Induction Chemotherapy 09/2016 - 04/2008
5	Neoadjuvant Therapy 11/2015 - 01/2009
3	Length of Stay 12/2022 - 01/2018
3	Bronchoscopes 10/2022 - 10/2016
3	Chemoradiotherapy 01/2014 - 02/2009
3	Resuscitation 05/2012 - 01/2007
2	Precision Medicine 01/2021 - 12/2013
2	Tracheostomy 01/2020 - 04/2015